Neuss MN, Gilmore TR, Belderson KM, Billett AL, Conti-Kalchik T, Harvet BE, et al. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. Oncol Nurs Forum 2017 Jan 6;44(1):31-43 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/28067033.
Compare quality appraisals for each clinical question
- Glossary of terms and abbreviations
- Guideline development process
- How is dosage of cancer therapy calculated for paediatric patients?
- How should chemotherapy be safely administered via different routes?
- How should information be presented in the medication order to minimise errors?
- How should information be presented on a medication label for cancer therapy to minimise errors?
- What actions should be performed post-administration of cancer therapy to maximise safety?
- What additional safety practices should be followed when providing oral cancer therapy?
- What are the documentation requirements to support the safe provision of cancer therapy?
- What are the responsibilities of the Nurse when administering cancer therapy?
- What are the responsibilities of the Prescriber when prescribing cancer therapy and associated medications?
- What competencies and skills are required when administering cancer therapy?
- What competencies and skills are required when dispensing and supplying cancer therapy?
- What information and assessments are required prior to administering cancer therapy?
- What information should be included in a treatment protocol for cancer therapy?
- What information should be provided to patients and carers about the cancer therapy?
- What is best practice when dispensing oral cancer treatment (chemotherapy and targeted therapy)?
- What is best practice when prescribing oral cancer treatment (chemotherapy and targeted therapy)?
- What is the procedure for the Nurse when verifying cancer therapy and related medication prior to administration?
- What is the procedure for the Pharmacist when clinically verifying cancer prescriptions?